Europe, Middle East & Africa
Embrace innovation. Accelerate oncology breakthroughs.
下一代疗法为癌症患者带来了更好的结果的希望。但是，随着新发现的发展，开发道路和更多未知数。我们在这里将您的肿瘤计划与解决方案联系起来，以支持您的成功。
Contact Us
您的科学突破值得采取新的发展方法
通过建立智能联系，我们为当今肿瘤学开发的需求带来了创新，以帮助您专注于患者，管理试验的复杂性并提高可预测性和速度。IQVIA帮助您
- 整合生物标志物策略, operations and partners from development plans through trial execution
- 设计和执行自适应和新颖的试验设计
- 使用患者见解betway必威怎么提款to improve trial design, speed recruitment and reduce patient burden
- Plan and executecell and gene therapy programswith specialized expertise and resources
- Optimize development plansby applying real world and commercial insights in clinical strategies and forecasting scenarios
- Apply AI and machine learning提高试验效率和患者安全
Related Solutions
利用现实世界数据的力量
Through advanced analytics, such as artificial intelligence and machine learning, coupled with our oncology expertise, IQVIA Oncology Commercial Solutions can help track the impact of clinical advancements in real world diagnosis and treatment patterns. By accelerating time to insights we help customers drive business decisions which, ultimately, impact patient care.
肿瘤学的趋势主题
研究所报告
Global Oncology Trends 2022
这份来自伊克维亚研究所（IQVIA Institute）全球肿瘤学的年度趋势报告研究了那些新型药物和研究簇，这些药物有望在未来十年中持续一系列突破。该报告探讨了CoVID-19中断和长期趋势在使用癌症药物的影响以及全球支出的驱动因素，主要地理位置，肿瘤类型以及特定类型的肿瘤学药物。